Logo Logo

Publications by Abenhardt, Wolfgang

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 5.

Journal article

Hartkopf, Andreas D.; Huober, Jens; Volz, Bernhard; Nabieva, Naiba; Taran, Florin-Andrei; Schwitulla, Judith; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lux, Michael P.; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Fersis, Nikos; Abenhardt, Wolfgang; Kurbacher, Christian; Würstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas (2018): Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry. In: Breast, Vol. 37: pp. 42-51

Schnell, Oliver; Thorsteinsdottir, Jun; Fleischmann, Daniel Felix; Lenski, Markus; Abenhardt, Wolfgang; Giese, Armin; Tonn, Jörg-Christian; Belka, Claus; Kreth, Friedrich Wilhelm; Niyazi, Maximilian (2016): Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma. In: Journal of Neuro-Oncology, Vol. 130, No. 3: pp. 591-599

Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion; Heinemann, Volker (2010): Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer. In: Oncology, No. 3-4: pp. 197-203 [PDF, 209kB]

Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion; Heinemann, Volker (2010): Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer. In: Oncology, No. 3-4: pp. 204-210 [PDF, 215kB]

Stemmler, J.; Mair, W.; Stauch, M.; Papke, J.; Deutsch, G.; Abenhardt, Wolfgang; Dorn, B.; Kentenich, C.; Malekmohammadi, M.; Jackisch, C.; Leinung, S.; Brudler, O.; Vehling-Kaiser, U.; Stamp, J.; Heinemann, Volker (2005): High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer. In: Oncology, No. 1: pp. 71-78 [PDF, 158kB]

This list was generated on Fri Aug 23 06:50:48 2019 CEST.